Advertisement
New Zealand markets closed

  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     

  • NZD/USD

    0.5889
    -0.0016 (-0.28%)
     

  • NZD/EUR

    0.5521
    -0.0023 (-0.42%)
     

  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     

  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     

  • OIL

    83.34
    +0.61 (+0.74%)
     

  • GOLD

    2,403.80
    +5.80 (+0.24%)
     

  • NASDAQ

    17,037.65
    -356.67 (-2.05%)
     

  • FTSE

    7,895.85
    +18.80 (+0.24%)
     

  • Dow Jones

    37,986.40
    +211.02 (+0.56%)
     

  • DAX

    17,737.36
    -100.04 (-0.56%)
     

  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • NZD/JPY

    91.0110
    -0.2430 (-0.27%)
     

Company News For Nov 27, 2018

Zacks

  • Zafgen, Inc.’s ZFGN shares plummeted 40.6% after the FDA put U.S. trials of the company’s experimental diabetes drug on hold, citing safety concerns

  • Shares of Cleveland-Cliffs Inc. CLF declined 1.3% after it announced a new $200 million stock buyback program

  • Aetna. Inc.’s AET shares gained 2.3% after CVS Health Corporation CVS received the final regulatory nod to acquire the company

  • Shares of GW Pharmaceuticals plc GWPH increased 2.9% after the company announced positive top-line results for its cannabinoid-based childhood-onset epilepsy treatment, Epidiolex


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
GW Pharmaceuticals PLC (GWPH) : Free Stock Analysis Report
 
Zafgen, Inc. (ZFGN) : Free Stock Analysis Report
 
Aetna Inc. (AET) : Free Stock Analysis Report
 
Cleveland-Cliffs Inc. (CLF) : Free Stock Analysis Report
 
CVS Health Corporation (CVS) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research